Opinion

SEP owners face a moment of maximum danger

Mobile devices will play a major role in the recovery from the covid-19 crisis - and that means how much they cost is going to come firmly under the microscope

25 April 2020

Intellectual Discovery and IP Bridge sales mark the end of an era

The state-backed patent funds helped change the culture around patents in the South Korea and Japan, and now both face the task of surviving the private sector

18 April 2020

WDTX judge says it's not a plaintiffs’ paradise, but that won’t stop rights owners flocking there

Judge Albright is becoming an increasingly important figure in the US IP system and it’s his patent background that marks him out from many of his peers

11 April 2020

People in rich countries have no right to free IP

It’s only because the developed world feels threatened by the coronavirus that initiatives such as the Open COVID pledge have gained such support

04 April 2020

This, too, shall pass ...

The world is hurting, times are tough, but even as they endure pain today IP professionals can look forward to a golden, new dawn

28 March 2020

Some licensors are taking a much more public stand in their FRAND fights - here's why

Recents moves by Nokia and InterDigital show that rights owners are beginning to realise that winning the PR battle is just as important as prevailing in court

21 March 2020

The danger COVID-19 presents to biopharma patent owners

If they were to mishandle their response to the coronavirus pandemic, innovative life sciences companies could further polarise opinion on IP protection in the sector

14 March 2020

Notice of postponement - IPBC Europe 2020 and IP Risk Management Europe 2020

New dates for both events, which had been scheduled to take place in the last week of March, will be announced as soon as possible

06 March 2020

It’s time to take a different approach to appointing the USPTO head

Taking a longer term view would bring consistency and might help US innovation policy at a time of rising tech competition from China and elsewhere

22 February 2020

The impact of Covid-19 will be felt across the global IP market

The race to patent a treatment for coronavirus in China is heating up, but its spread could be the story that affects every other story in tech this year

15 February 2020

Iancu makes US concerns about possible Chinese WIPO leadership clear

USPTO head tells Washington DC event that the next head of the organisation must come from a country that “respects intellectual property rights”

06 February 2020

We need better thinking on US pharma patent reforms

As the presidential race heats up - and with even self-styled Democrat centrist Michael Bloomberg now promising radical regime change - life sciences IP professionals must interject some sanity into the debate

01 February 2020

The EU should not contemplate abandoning the Unified Patent Court system

Ratification delay in Germany and the spectre of UK non-participation mean many believe the project will quietly be dropped - but to do so would be a serious mistake

11 January 2020

Even if you forget about 101 reform, don’t forget about DC

The prospects of legislation on patent eligibility may have diminished but the significance of IP policy discussions is only getting greater

14 December 2019

IoT patent owners still hold the future in their own hands – but the clock is ticking

A successful IAM conference in Munich illustrated the IP complexities that surround the platform, but licensors must think creatively - and quickly - about how to seize opportunities before others do it for them

30 November 2019

Patents are politics, as an eagerly awaited UK Supreme Court FRAND licensing ruling may soon show

A judgment that upholds the Unwired Planet and Conversant decisions could well leave British Prime Minister Boris Johnson in a difficult position

16 November 2019

The patent dodgers trolling the IP landscape

IPCom is one of Europe’s oldest NPEs – and usually one of its most reticent. Not anymore, though. In this opinion piece, managing director Pio Suh explains why he believes firms such as his have a key role to play in FRAND licensing

09 November 2019

UK general election could result in a paradigm shift on pharma IP

The Labour Party – the main opposition to Boris Johnson’s Conservatives – recently set out a radical plan to change the patent regime for life sciences innovators

02 November 2019

Get unlimited access to all IAM content